The genesis of ABC Labs
ABC Labs was built in the midst of a global pandemic, quickly becoming the largest pandemic lab in Sweden. Now we are deploying our next generation diagnostics infrastructure to corporate and organizational drug testing, one of the largest societal challenges today.
ABC Labs was built and deployed in 8 weeks, as a response to the global pandemic.
We launched an extraction-free PCR test methodology, designed in-house, resulting in a seminal publication.
We launched the first clinical T-cell test in Europe, used to study immunity in healthcare workers and short and long-term response in immunocompromised patients.
We launched NGS, Next Generation Sequencing, to identify and monitor unknown and novel virus mutations.
We became the first private lab to be able to identify the Delta variant, garnering a large portion of all positive samples in Sweden being sent to ABC Labs.
We developed a fully in-house PCR kit and methodology to set up the largest Omicron screening program in Sweden.
National Covid-testing ended. During the pandemic, we played a pivotal role with up to 28% of Sweden's PCR tests and won 12 regional tenders for future pandemic lab analysis.
We launched testing of substances, by utilizing learnings, infrastructure and our team created during the pandemic.
